Ekso Bionics Holdings, Inc. (EKSO) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending September 2025, Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) is held by 31 institutional firms.

• Ekso Bionics Holdings saw its institutional ownership percentage rose to 7.5% in September 2025 from 3.3% in June 2025.
• In percentage terms, this reflects as a holdings change of 246.62% quarter on quarter, and an increase of 6.90% year over year.
• Of these 31 institutional investors, 11 increased their holdings in Ekso Bionics Holdings, while 4 of them reduced positions, and 16 investors maintained their exposure.
• Collectively, institutional investors increased their stake in Ekso Bionics Holdings to 196.63K shares as of September 2025, a change that is up by 139.91K shares quarter on quarter and down 5.15Mn shares year over year.
• CITADEL ADVISORS LLC's holding of 38.55K shares as of September 30, 2025 makes it the primary institutional investor in Ekso Bionics Holdings, owning 1.46% of the stock.
• Among the most significant buyers of Ekso Bionics Holdings during September 2025 were CITADEL ADVISORS LLC (38.55K), UBS Group AG (32.46K), VANGUARD GROUP INC (23.49K), DRW Securities, LLC (20.19K), Shay Capital LLC (13.00K).
• Leading sellers of Ekso Bionics Holdings stock in September 2025 included Tower Research Capital LLC (TRC) (901), FNY Investment Advisers, LLC (874), MORGAN STANLEY (66), OSAIC HOLDINGS, INC. (4).
• The top 10 institutional holders of Ekso Bionics Holdings for the quarter ending September 2025 included CITADEL ADVISORS LLC (38.55K), VANGUARD GROUP INC (35.45K), UBS Group AG (32.46K), DRW Securities, LLC (20.19K), Cresset Asset Management, LLC (17.96K), GEODE CAPITAL MANAGEMENT, LLC (14.93K), Shay Capital LLC (13.00K), Virtu Financial LLC (11.11K), BlackRock, Inc. (3.65K), FNY Investment Advisers, LLC (2.62K).